Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 10 | 2024 | 138 | 5.200 |
Why?
|
| Microbiota | 5 | 2023 | 81 | 3.600 |
Why?
|
| Stress Disorders, Post-Traumatic | 21 | 2024 | 363 | 3.570 |
Why?
|
| Dysbiosis | 6 | 2022 | 45 | 3.100 |
Why?
|
| Frailty | 4 | 2022 | 127 | 2.550 |
Why?
|
| Anti-Bacterial Agents | 8 | 2022 | 641 | 2.220 |
Why?
|
| Soft Tissue Infections | 4 | 2020 | 42 | 1.850 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2020 | 77 | 1.810 |
Why?
|
| Emergency Service, Hospital | 11 | 2022 | 962 | 1.710 |
Why?
|
| Clostridium Infections | 2 | 2021 | 39 | 1.310 |
Why?
|
| Nursing Homes | 5 | 2022 | 651 | 1.260 |
Why?
|
| Aging | 2 | 2024 | 705 | 1.130 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2016 | 30 | 1.030 |
Why?
|
| Diarrhea | 2 | 2016 | 69 | 1.010 |
Why?
|
| Pneumonia, Bacterial | 2 | 2018 | 79 | 1.010 |
Why?
|
| Influenza, Human | 3 | 2014 | 185 | 0.870 |
Why?
|
| Guideline Adherence | 3 | 2020 | 296 | 0.830 |
Why?
|
| Aged | 19 | 2023 | 12314 | 0.820 |
Why?
|
| Humans | 56 | 2024 | 55560 | 0.820 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 70 | 0.800 |
Why?
|
| Treatment Failure | 3 | 2021 | 179 | 0.770 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 15 | 0.760 |
Why?
|
| Alzheimer Disease | 3 | 2023 | 477 | 0.760 |
Why?
|
| Prospective Studies | 11 | 2023 | 2862 | 0.720 |
Why?
|
| Polysaccharides | 1 | 2021 | 122 | 0.710 |
Why?
|
| Skin Diseases, Infectious | 2 | 2016 | 9 | 0.690 |
Why?
|
| Inappropriate Prescribing | 1 | 2020 | 61 | 0.680 |
Why?
|
| Adult | 24 | 2024 | 14649 | 0.660 |
Why?
|
| Depressive Disorder, Major | 4 | 2023 | 261 | 0.650 |
Why?
|
| Inflammation | 3 | 2022 | 1057 | 0.650 |
Why?
|
| Male | 26 | 2024 | 25482 | 0.630 |
Why?
|
| Macrolides | 1 | 2018 | 33 | 0.620 |
Why?
|
| Antacids | 1 | 2017 | 11 | 0.610 |
Why?
|
| Female | 28 | 2024 | 29019 | 0.610 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 613 | 0.600 |
Why?
|
| Community-Acquired Infections | 1 | 2018 | 86 | 0.600 |
Why?
|
| Independent Living | 1 | 2017 | 43 | 0.600 |
Why?
|
| Bacterial Infections | 2 | 2023 | 136 | 0.590 |
Why?
|
| Feces | 3 | 2023 | 83 | 0.580 |
Why?
|
| Nutritional Status | 1 | 2017 | 121 | 0.570 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 132 | 0.560 |
Why?
|
| Outpatients | 1 | 2016 | 122 | 0.530 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2015 | 5 | 0.530 |
Why?
|
| Middle Aged | 18 | 2024 | 14979 | 0.520 |
Why?
|
| Hyphae | 1 | 2014 | 13 | 0.500 |
Why?
|
| Mediator Complex | 1 | 2014 | 13 | 0.500 |
Why?
|
| Bacteria | 3 | 2024 | 250 | 0.500 |
Why?
|
| Candida albicans | 1 | 2014 | 54 | 0.490 |
Why?
|
| Hemagglutinins, Viral | 1 | 2014 | 19 | 0.480 |
Why?
|
| Administration, Intravenous | 1 | 2014 | 52 | 0.480 |
Why?
|
| RNA, Ribosomal, 16S | 4 | 2023 | 60 | 0.480 |
Why?
|
| Fungal Proteins | 1 | 2014 | 141 | 0.470 |
Why?
|
| Respiratory Tract Infections | 1 | 2014 | 76 | 0.460 |
Why?
|
| Antibodies, Viral | 2 | 2023 | 306 | 0.460 |
Why?
|
| Aged, 80 and over | 8 | 2021 | 4700 | 0.440 |
Why?
|
| Machine Learning | 3 | 2024 | 119 | 0.420 |
Why?
|
| Accidents, Traffic | 6 | 2022 | 144 | 0.410 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 175 | 0.390 |
Why?
|
| Virus Diseases | 1 | 2012 | 121 | 0.390 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2022 | 722 | 0.380 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2024 | 1758 | 0.380 |
Why?
|
| Longitudinal Studies | 7 | 2024 | 1177 | 0.350 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 648 | 0.340 |
Why?
|
| Cytokines | 1 | 2013 | 877 | 0.330 |
Why?
|
| Wounds and Injuries | 2 | 2021 | 233 | 0.330 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2014 | 89 | 0.320 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 1310 | 0.320 |
Why?
|
| Depression | 7 | 2023 | 856 | 0.310 |
Why?
|
| Young Adult | 9 | 2024 | 3992 | 0.310 |
Why?
|
| Pain | 3 | 2023 | 396 | 0.300 |
Why?
|
| Motor Vehicles | 6 | 2023 | 37 | 0.300 |
Why?
|
| Health Personnel | 2 | 2021 | 346 | 0.300 |
Why?
|
| Risk Factors | 6 | 2023 | 4683 | 0.290 |
Why?
|
| Wrist | 2 | 2023 | 29 | 0.270 |
Why?
|
| Psychological Trauma | 2 | 2024 | 25 | 0.250 |
Why?
|
| ROC Curve | 3 | 2021 | 249 | 0.250 |
Why?
|
| Gray Matter | 1 | 2023 | 24 | 0.230 |
Why?
|
| Longevity | 1 | 2024 | 103 | 0.230 |
Why?
|
| Internal Capsule | 1 | 2023 | 11 | 0.220 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 887 | 0.220 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2023 | 13 | 0.220 |
Why?
|
| Biological Availability | 1 | 2023 | 163 | 0.220 |
Why?
|
| Cohort Studies | 4 | 2021 | 2302 | 0.220 |
Why?
|
| Heart Rate | 1 | 2024 | 278 | 0.220 |
Why?
|
| Dreams | 1 | 2022 | 3 | 0.220 |
Why?
|
| Prevalence | 3 | 2021 | 1190 | 0.220 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 67 | 0.220 |
Why?
|
| Dissociative Disorders | 1 | 2022 | 7 | 0.210 |
Why?
|
| Fear | 1 | 2023 | 62 | 0.210 |
Why?
|
| Cannabis | 1 | 2023 | 45 | 0.210 |
Why?
|
| Acute Pain | 1 | 2022 | 18 | 0.210 |
Why?
|
| Sex Characteristics | 1 | 2024 | 201 | 0.210 |
Why?
|
| Smartphone | 1 | 2023 | 56 | 0.210 |
Why?
|
| Wearable Electronic Devices | 1 | 2023 | 61 | 0.200 |
Why?
|
| Logistic Models | 2 | 2016 | 1242 | 0.200 |
Why?
|
| Child Abuse | 1 | 2023 | 87 | 0.200 |
Why?
|
| Functional Neuroimaging | 1 | 2021 | 16 | 0.200 |
Why?
|
| Insulins | 1 | 2022 | 15 | 0.200 |
Why?
|
| White Matter | 1 | 2023 | 106 | 0.200 |
Why?
|
| Blood Pressure | 1 | 2024 | 509 | 0.200 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 6 | 0.200 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 156 | 0.190 |
Why?
|
| Abscess | 1 | 2021 | 74 | 0.190 |
Why?
|
| Human Development | 1 | 2020 | 10 | 0.190 |
Why?
|
| Drainage | 1 | 2021 | 120 | 0.190 |
Why?
|
| Adolescent | 6 | 2023 | 5669 | 0.190 |
Why?
|
| Massachusetts | 2 | 2017 | 2101 | 0.190 |
Why?
|
| Health | 1 | 2020 | 33 | 0.190 |
Why?
|
| Proton Pump Inhibitors | 1 | 2021 | 36 | 0.190 |
Why?
|
| Virus Replication | 1 | 2002 | 281 | 0.190 |
Why?
|
| Monocytes | 1 | 2002 | 346 | 0.180 |
Why?
|
| Sleep Wake Disorders | 1 | 2021 | 68 | 0.180 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2019 | 10 | 0.180 |
Why?
|
| Models, Theoretical | 1 | 2021 | 256 | 0.180 |
Why?
|
| Anxiety | 4 | 2023 | 384 | 0.170 |
Why?
|
| Psychometrics | 1 | 2021 | 370 | 0.170 |
Why?
|
| Metagenomics | 1 | 2019 | 15 | 0.170 |
Why?
|
| Diet | 1 | 2024 | 648 | 0.170 |
Why?
|
| Self Care | 1 | 2021 | 207 | 0.170 |
Why?
|
| Occupational Diseases | 1 | 2021 | 259 | 0.170 |
Why?
|
| Ambulatory Care | 1 | 2021 | 271 | 0.160 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 69 | 0.160 |
Why?
|
| Intestines | 1 | 2019 | 152 | 0.160 |
Why?
|
| Biomarkers | 2 | 2013 | 1083 | 0.150 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 1931 | 0.150 |
Why?
|
| Brain | 5 | 2024 | 1379 | 0.150 |
Why?
|
| Paracentesis | 1 | 2016 | 13 | 0.140 |
Why?
|
| Homeostasis | 1 | 2019 | 327 | 0.140 |
Why?
|
| Epithelial Cells | 1 | 2019 | 359 | 0.140 |
Why?
|
| HIV-1 | 1 | 2002 | 696 | 0.140 |
Why?
|
| Multicenter Studies as Topic | 1 | 2016 | 100 | 0.140 |
Why?
|
| Telemedicine | 1 | 2021 | 297 | 0.140 |
Why?
|
| Age Distribution | 1 | 2016 | 257 | 0.140 |
Why?
|
| Recurrence | 1 | 2017 | 528 | 0.140 |
Why?
|
| Dementia | 1 | 2019 | 228 | 0.140 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 673 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 399 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 1036 | 0.130 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 428 | 0.130 |
Why?
|
| HIV Infections | 1 | 2002 | 887 | 0.130 |
Why?
|
| Case-Control Studies | 3 | 2023 | 1004 | 0.130 |
Why?
|
| United States | 4 | 2021 | 7084 | 0.130 |
Why?
|
| Algorithms | 1 | 2020 | 954 | 0.120 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2014 | 10 | 0.120 |
Why?
|
| Virulence | 1 | 2014 | 178 | 0.120 |
Why?
|
| Mental Disorders | 1 | 2021 | 727 | 0.120 |
Why?
|
| Antibody Formation | 1 | 2014 | 111 | 0.120 |
Why?
|
| HLA-DR3 Antigen | 1 | 2013 | 6 | 0.120 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2014 | 119 | 0.120 |
Why?
|
| Femoral Nerve | 1 | 2013 | 5 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 285 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2014 | 334 | 0.110 |
Why?
|
| Morphine | 1 | 2013 | 52 | 0.110 |
Why?
|
| Nerve Block | 1 | 2013 | 32 | 0.110 |
Why?
|
| Escherichia coli | 1 | 2017 | 671 | 0.110 |
Why?
|
| Prefrontal Cortex | 2 | 2024 | 110 | 0.110 |
Why?
|
| Psychopathology | 2 | 2023 | 20 | 0.110 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 194 | 0.110 |
Why?
|
| Sex Factors | 1 | 2015 | 913 | 0.110 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2013 | 190 | 0.110 |
Why?
|
| Hip Fractures | 1 | 2013 | 76 | 0.110 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 186 | 0.110 |
Why?
|
| Influenza Vaccines | 1 | 2013 | 85 | 0.110 |
Why?
|
| Amygdala | 2 | 2023 | 76 | 0.100 |
Why?
|
| Survivors | 2 | 2023 | 150 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2014 | 797 | 0.100 |
Why?
|
| Pain Management | 1 | 2013 | 129 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2021 | 5480 | 0.100 |
Why?
|
| Animals | 5 | 2023 | 18927 | 0.100 |
Why?
|
| Trauma Centers | 1 | 2012 | 113 | 0.100 |
Why?
|
| Age Factors | 1 | 2015 | 1489 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2021 | 4550 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2012 | 568 | 0.100 |
Why?
|
| Anxiety Disorders | 2 | 2023 | 182 | 0.090 |
Why?
|
| Neuroimaging | 2 | 2022 | 111 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 808 | 0.090 |
Why?
|
| Disease Progression | 1 | 2014 | 881 | 0.090 |
Why?
|
| Emergency Medical Services | 1 | 2013 | 235 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 902 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 606 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2023 | 1283 | 0.080 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 410 | 0.080 |
Why?
|
| Paecilomyces | 1 | 2008 | 2 | 0.080 |
Why?
|
| Bursitis | 1 | 2008 | 10 | 0.080 |
Why?
|
| Mycoses | 1 | 2008 | 41 | 0.080 |
Why?
|
| Prognosis | 2 | 2021 | 1376 | 0.070 |
Why?
|
| Mutation | 1 | 2014 | 2325 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 2368 | 0.070 |
Why?
|
| Child | 3 | 2022 | 4163 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2021 | 418 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 1195 | 0.070 |
Why?
|
| Vaccines, Combined | 1 | 2023 | 7 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2024 | 127 | 0.060 |
Why?
|
| Hydroxy Acids | 1 | 2023 | 2 | 0.060 |
Why?
|
| Bacteroides fragilis | 1 | 2023 | 5 | 0.060 |
Why?
|
| Bacteroides | 1 | 2023 | 8 | 0.060 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 466 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2023 | 35 | 0.060 |
Why?
|
| Anisotropy | 1 | 2023 | 67 | 0.060 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 35 | 0.060 |
Why?
|
| Seroepidemiologic Studies | 1 | 2023 | 46 | 0.050 |
Why?
|
| Nerve Net | 1 | 2023 | 90 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2024 | 236 | 0.050 |
Why?
|
| Gyrus Cinguli | 1 | 2023 | 57 | 0.050 |
Why?
|
| Mice | 3 | 2023 | 9907 | 0.050 |
Why?
|
| Hippocampus | 1 | 2024 | 225 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2002 | 90 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2023 | 94 | 0.050 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 29 | 0.050 |
Why?
|
| Precipitating Factors | 1 | 2021 | 3 | 0.050 |
Why?
|
| Biological Variation, Individual | 1 | 2021 | 4 | 0.050 |
Why?
|
| Psychophysiology | 1 | 2021 | 6 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2022 | 34 | 0.050 |
Why?
|
| Trauma Severity Indices | 1 | 2021 | 37 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2023 | 447 | 0.050 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 43 | 0.050 |
Why?
|
| Immunization Schedule | 1 | 2021 | 19 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2022 | 100 | 0.050 |
Why?
|
| Life Change Events | 1 | 2021 | 66 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 437 | 0.050 |
Why?
|
| Microglia | 1 | 2023 | 202 | 0.050 |
Why?
|
| Self Report | 1 | 2023 | 369 | 0.050 |
Why?
|
| Vaccination | 1 | 2023 | 319 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2021 | 393 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2021 | 481 | 0.040 |
Why?
|
| Sleep | 1 | 2023 | 218 | 0.040 |
Why?
|
| Emotions | 1 | 2022 | 219 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 94 | 0.040 |
Why?
|
| Cognition | 1 | 2022 | 446 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2023 | 1450 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2021 | 361 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2021 | 1739 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 2502 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 46 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2013 | 18 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2013 | 260 | 0.030 |
Why?
|
| New England | 1 | 2013 | 263 | 0.030 |
Why?
|
| Analgesia | 1 | 2013 | 28 | 0.030 |
Why?
|
| Viral Load | 1 | 2013 | 222 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 152 | 0.030 |
Why?
|
| Veterans | 1 | 2019 | 699 | 0.030 |
Why?
|
| Lung | 1 | 2013 | 682 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2013 | 497 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1500 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 1813 | 0.020 |
Why?
|
| Ketoconazole | 1 | 2008 | 8 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Fungal | 1 | 2008 | 4 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2008 | 90 | 0.020 |
Why?
|